Results 211 to 220 of about 553,015 (386)
A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen +14 more
wiley +1 more source
Kan man overhovedet stole på uddannelsesforskningen, når den ikke tager højde for den effect, forskeres og læreres entusiasme i forhold til en ny metode kan have for resultaterne?
openaire +2 more sources
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley +1 more source
Talking placebo: a qualitative study of patients' attitudes toward open-label placebo implementation into clinical practice. [PDF]
Frey Nascimento A +8 more
europepmc +1 more source

